Sofosbuvir, a NS5B polymerase inhibitor in the treatment of hepatitis C: a review of its clinical potential
about
Sofosbuvir, a Significant Paradigm Change in HCV TreatmentMiR-122 in hepatitis B virus and hepatitis C virus dual infectionSpatiotemporal analysis of hepatitis C virus infectionDaclatasvir inhibits hepatitis C virus NS5A motility and hyper-accumulation of phosphoinositides.Fast hepatitis C virus RNA elimination and NS5A redistribution by NS5A inhibitors studied by a multiplex assay approachHIV and HCV Medications in End-Stage Renal Disease.Treatment of Chronic Hepatitis C Infection with Sofosbuvir-Based Regimens in a Commercially Insured Patient PopulationAsunaprevir-containing regimens for the treatment of hepatitis C virus infection.Optimizing triple therapy and IFN/RBV-free regimens for hepatitis C virus infection.Development of antiviral drugs for the treatment of hepatitis C at an accelerating pace.Development of sofosbuvir for the treatment of hepatitis C virus infection.Pharmacokinetic drug evaluation of velpatasvir plus sofosbuvir for the treatment of hepatitis C virus infection.Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients.Discovery of a Broad-Spectrum Antiviral Compound That Inhibits Pyrimidine Biosynthesis and Establishes a Type 1 Interferon-Independent Antiviral State.The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C.Control of HCV Replication With iMIRs, a Novel Anti-RNAi Agent.Rapid virological&End treatment response of patients treated with Sofosbuvir in Chronic Hepatitis CSofosbuvir: A Nucleotide NS5B Inhibitor for the Treatment of Chronic Hepatitis C Infection.Flexibility-Not just for yoga anymore!Effect of Sofosbuvir Plus Daclatasvir in Hepatitis C Virus Genotype-4 Patients: Promising Effect on Liver Fibrosis.Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses.Lobohedleolide suppresses hepatitis C virus replication via JNK/c-Jun-C/EBP-mediated down-regulation of cyclooxygenase-2 expression.Oncoprotein Stathmin Modulates Sensitivity to Apoptosis in Hepatocellular Carcinoma Cells During Hepatitis C Viral Replication
P2860
Q26781773-6E8283D2-1D99-4C49-8E5F-6C27AAD5A7DAQ27008894-67A420D7-B51B-4F1E-A040-8320C5F680A4Q27320822-A0C9C1DF-B685-4180-95AF-37EC649E3A4FQ35070501-3EFE03AE-BDEE-4820-B728-0813461A6BC4Q35607835-39913B6F-508B-44C7-BF92-7E0B6308658EQ35832564-787310F3-0737-47F1-B2C3-26A8D70E9A6EQ37441421-56445E4C-7D22-4868-B536-4D210D3BCED7Q38244931-A43194A1-6E44-4094-BBAD-7E96889EED24Q38249065-D442C725-40C3-4CD9-8B5C-89118A895E8DQ38515906-20086FB5-F2CB-4875-A040-C2E013A56340Q38559442-0414130B-34E2-4E4B-ADB9-B0649502FC43Q38976791-F5D505B4-3FEE-40AC-9B4A-55809F220C82Q38991020-C184B39B-8F49-459B-BFEA-E413A2884223Q40105589-7BA53FA8-2E87-4ECC-AD44-AD0A08C48B58Q40326326-755252AD-5285-4AB7-A0A4-AF8BF4706096Q42175896-CAFD3512-6CD5-4CBE-A329-AFD696C2A132Q42669690-AD701F3C-864A-4D43-B7A9-C738A75C83E3Q50283110-B37AFEA3-AA0F-4C10-8C0F-DDCB891CA27EQ52691809-D97562AA-0463-48F8-8197-F4E84A9F2724Q53684076-DC5FF3CA-32E8-4118-9F49-904DC26F6DC4Q54256710-EA642032-89D7-4D14-9F43-3259F9CCCE3DQ54976857-1B5ECCAD-7467-4824-98F9-1166B0338715Q57177206-D836CF83-95A5-4A2B-B2EA-4DC266192C66
P2860
Sofosbuvir, a NS5B polymerase inhibitor in the treatment of hepatitis C: a review of its clinical potential
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Sofosbuvir, a NS5B polymerase ...... view of its clinical potential
@ast
Sofosbuvir, a NS5B polymerase ...... view of its clinical potential
@en
Sofosbuvir, a NS5B polymerase ...... view of its clinical potential
@nl
type
label
Sofosbuvir, a NS5B polymerase ...... view of its clinical potential
@ast
Sofosbuvir, a NS5B polymerase ...... view of its clinical potential
@en
Sofosbuvir, a NS5B polymerase ...... view of its clinical potential
@nl
prefLabel
Sofosbuvir, a NS5B polymerase ...... view of its clinical potential
@ast
Sofosbuvir, a NS5B polymerase ...... view of its clinical potential
@en
Sofosbuvir, a NS5B polymerase ...... view of its clinical potential
@nl
P2860
P356
P1476
Sofosbuvir, a NS5B polymerase ...... view of its clinical potential
@en
P2093
C. Stedman
P2860
P304
P356
10.1177/1756283X13515825
P407
P577
2014-05-01T00:00:00Z